Diabetes Kongress 2022
zur Liste
Dr. Ines Witte
Novo Nordisk Pharma GmbH Germany
  • Vortrag Real-world use of once-weekly semaglutide in diverse patient populations with type 2 diabetes: pooled analysis of four SURE studies Speaker
    Datum: 27.05.2022 , Zeit: 11:12 | Thema: Poster
    Details